Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients
November 21, 2019 07:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that Japan’s Ministry of Health, Labour...
Federal study finds rampant bias in medical “futile care” decisions
November 20, 2019 12:31 ET
|
National Council on Disability
WASHINGTON, Nov. 20, 2019 (GLOBE NEWSWIRE) -- WASHINGTON – Today, the National Council on Disability (NCD)—an independent federal agency that advises the President and Congress-- released a study...
S. Parikh Mars, Progressive Care CEO, Answers Shareholder Questions in Exclusive New Interview at SmallCapVoice.com
November 20, 2019 08:00 ET
|
SmallCapVoice.com; Progressive Care Inc.
MIAMI, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has recently answer...
The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis
November 20, 2019 07:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced that the American College of...
Pillar Marketing Group, Inc., Announces Acquisition Purchase of Controlling interest in Select-TV Solutions, Inc., Changing their name to BioQuest Corp. and Appoints Thomas Hemingway as Chairman and CEO.
November 18, 2019 08:15 ET
|
BioQuest Corp
Newport Beach, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioQuest Corp, (BQST or the “COMPANY”) (OTC:BQST), (the temporary symbol on 11/15/2019 is SELTD. Please note that a “D” has been appended as the...
H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD
November 18, 2019 08:00 ET
|
H-CYTE, Inc.
TAMPA, Fla., Nov. 18, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute,...
BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
November 18, 2019 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BIOMEDevice San Jose Announces 2019 Content to Support Digital Health Innovation Enhancing the Patient Experience
November 14, 2019 11:02 ET
|
BioMEDDevice / ESC San Jose
SANTA MONICA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- BIOMEDevice San Jose, Silicon Valley’s leading event for medtech professionals, today announced its 2019 show focus on digital health...
BioSig Technologies Issues November 2019 Shareholder Letter
November 14, 2019 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 14, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
NewLink Genetics Announces European Commission Grant of Conditional Marketing Approval for Ebola Vaccine V920 (ERVEBO®)
November 12, 2019 09:00 ET
|
NewLink Genetics Corporation
AMES, Iowa, Nov. 12, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced that Monday, November 11th, the European Commission (EC) granted a conditional marketing...